2+ signaling is implicated in a variety of cardiac arrhythmias, including catecholaminergic polymorphic ventricular tachycardia. Spontaneous diastolic Ca 2+ release (DCR) can induce arrhythmogenic plasma membrane depolarizations, although the mechanism responsible for DCR synchronization among adjacent myocytes required for ectopic activity remains unclear. We investigated the synchronization mechanism(s) of DCR underlying untimely action potentials and diastolic contractions (DCs) in a catecholaminergic polymorphic ventricular tachycardia mouse model with a mutation in cardiac calsequestrin. We used a combination of different approaches including single ryanodine receptor channel recording, optical imaging (Ca 2+ and membrane potential), and contractile force measurements in ventricular myocytes and intact cardiac muscles. We demonstrate that DCR occurs in a temporally and spatially uniform manner in both myocytes and intact myocardial tissue isolated from cardiac calsequestrin mutation mice. Such synchronized DCR events give rise to triggered electrical activity that results in synchronous DCs in the myocardium. Importantly, we establish that synchronization of DCR is a result of a combination of abbreviated ryanodine receptor channel refractoriness and the preceding synchronous stimulated Ca 2+ release/reuptake dynamics. Our study reveals how aberrant DCR events can become synchronized in the intact myocardium, leading to triggered activity and the resultant DCs in the settings of a cardiac rhythm disorder.
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2+ signaling is implicated in a variety of cardiac arrhythmias, including catecholaminergic polymorphic ventricular tachycardia. Spontaneous diastolic Ca 2+ release (DCR) can induce arrhythmogenic plasma membrane depolarizations, although the mechanism responsible for DCR synchronization among adjacent myocytes required for ectopic activity remains unclear. We investigated the synchronization mechanism(s) of DCR underlying untimely action potentials and diastolic contractions (DCs) in a catecholaminergic polymorphic ventricular tachycardia mouse model with a mutation in cardiac calsequestrin. We used a combination of different approaches including single ryanodine receptor channel recording, optical imaging (Ca 2+ and membrane potential), and contractile force measurements in ventricular myocytes and intact cardiac muscles. We demonstrate that DCR occurs in a temporally and spatially uniform manner in both myocytes and intact myocardial tissue isolated from cardiac calsequestrin mutation mice. Such synchronized DCR events give rise to triggered electrical activity that results in synchronous DCs in the myocardium. Importantly, we establish that synchronization of DCR is a result of a combination of abbreviated ryanodine receptor channel refractoriness and the preceding synchronous stimulated Ca 2+ release/reuptake dynamics. Our study reveals how aberrant DCR events can become synchronized in the intact myocardium, leading to triggered activity and the resultant DCs in the settings of a cardiac rhythm disorder.
calcium-induced calcium release | luminal calcium | RyR2 deactivation | sarcoplasmic reticulum C ardiac arrhythmias are the most common and lethal cardiac diseases, accounting for around 450,000 deaths annually in the United States alone (1) . The majority of these deaths are caused by irregular ectopic beats that lead to ventricular tachycardia and fibrillation. The normal rhythmic beating of the heart is maintained by the cross-talk between the action potential (AP) and self-regenerating Ca 2+ -induced Ca 2+ release (CICR), where Ca 2+ entry during the cardiac AP ignites CICR. The CICR is mediated by the ryanodine receptor (RyR2) on the sarcoplasmic reticulum (SR) and contributes to the global intracellular Ca 2+ transient that drives cardiomyocyte contraction. Following Ca 2+ release and contraction, relaxation ensues as Ca 2+ is resequestered back into the SR by the SR Ca 2+ pump (2) . Importantly for normal Ca 2+ cycling, the SR becomes refractory after each systolic Ca 2+ release, thereby preventing spontaneous reactivation of CICR during the diastolic period (3) (4) (5) . This temporal restraint of Ca 2+ signaling is thought to be a consequence of the local decrease in intra-SR Ca 2+ that in turn can inhibit CICR either by reducing RyR2 Ca 2+ efflux (6) and/or by deactivating RyR2s via a mechanism that involves the SR Ca 2+ binding protein calsequestrin 2 (CASQ2) (7-9).
In various disease settings, aberrant diastolic Ca 2+ release (DCR) from the SR gives rise to arrhythmic ectopic activity (10) (11) (12) (13) (14) . The pathologic link between diastolic dysregulated Ca 2+ release and arrhythmia is particularly evident in catecholaminergic polymorphic ventricular tachycardia (CPVT), a familial form of arrhythmia caused by mutations in the components of the RyR2 complex, including RyR2 and CASQ2 (15, 16) . In myocytes harboring CPVT-associated CASQ2 mutations, altered CASQ2-dependent RyR2 modulation predisposes the SR to spontaneous DCR. DCR occurs in the form of waves of self-propagating CICR. These waves result in Ca 2+ -dependent depolarizing currents generated by the electrogenic Na + /Ca 2+ exchanger activity on the cell membrane giving rise to delayed afterdepolarizations (DADs) and consequently to triggered arrhythmias (17) (18) (19) .
Despite the fact that the mechanisms of triggered arrhythmias have been well established on the cellular level, the relationship between abnormal myocyte Ca 2+ cycling and focal excitation at the tissue level remains poorly understood. A key unresolved question is how spontaneous Ca 2+ release in individual myocytes can cause a sufficiently large membrane depolarization to elicit an ectopic event across the whole of myocardium, particularly because a local depolarizing current is expected to be absorbed by the electrically connected neighboring myocytes serving as current sinks (20) . Consequently, it has been suggested that ectopic activity, rather than arising in individual ventricular myocytes, originates in the Purkinje system, which has a smaller source-sink mismatch relative to the 3D ventricular network (21) . Thus, there is uncertainty whether and how focally activated arrhythmias such as CPVT can originate in the ventricular myocardium. Here, our focus is a murine model of CPVT with a point mutation in CASQ2 (CASQ2 R33Q ) that causes an impairment of storedependent RyR2 deactivation (22) . We demonstrate that this impairment alters refractoriness of Ca 2+ release, which in turn provides a mechanism for synchronization of DCR, DADs, and diastolic contractions (DCs) across intact myocardium. Importantly, our study provides a conceptual framework in which store-dependent RyR2 deactivation on the cellular level serves as a substrate for triggered arrhythmias at the whole heart level. hearts were paced at 1 Hz in the presence of the β-adrenergic agonist isoproterenol (ISO, 100 nM, Fig. 1A ). Under these conditions, DCR (waves and/or wavelets) occurred at a frequency of 0.24 ± 0.06 events per cycle in CASQ2 R33Q myocytes, which was significantly higher than those in WT myocytes (0.03 ± 0.01 events per cycle, Fig.  1C ). The few DCRs observed in WT myocytes were randomly distributed through diastole. In contrast, DCRs in CASQ2 R33Q cells had a high probability of occurrence around three distinct time points consistent with the development of up to three DCRs during the diastolic period. The distribution of DCRs reveals a well-defined periodicity with a fixed interrelease interval of ∼260 ms (Fig. 1D) . Of note, the occurrence of DCR displayed a clear rate dependency such that the number of events per cycle decreased and their distribution narrowed at faster pacing rates (Fig. S1 ).
Results

Spontaneous
To gain further insights into the mechanisms of DCR, we examined more closely the distribution of the latencies to the first DCR. In CASQ2 R33Q myocytes, the histogram after an initial time lag of ∼200 ms showed a sharp peak followed by a gradual, close to exponential decay (Fig. 1E) . As demonstrated by Maltsev et al. (23) in pacemaker cells with robust Ca 2+ oscillations, the high synchronicity of spontaneous firing of release sites is attributable to synchronization of refractory periods. Thus, the 200-ms time lag before the first DCR in CASQ2 R33Q myocytes provides a metric consistent with the RyR2 refractory period. In contrast, DCRs in WT myocytes were less frequent and occurred more randomly, with a median time of onset occurring at 751 ms, which was distinctly longer relative to CASQ2 R33Q myocytes (Fig. 1F) . Based on previous work by Maltsev et al. (23) , the increased synchronicity of release events in CASQ2 R33Q cells could be ascribed to either an increased magnitude of Ca 2+ release through RyR2s and/or altered refractory properties of RyR2s (facilitating CICR). Because the amplitude of Ca 2+ transients decreased in CASQ2 R33Q compared with WT myocytes (Fig.  1B) , an alteration in refractoriness of release is the likely factor behind the increased synchronicity of DCR during CPVT.
To more closely assess the refractory properties of Ca 2+ signaling in CASQ2 R33Q and WT myocytes, we measured the restitution of SR Ca 2+ release using an established S1-S2 protocol in which the first stimulus is followed by a second one after a varying time interval (Fig. 2A) . This protocol revealed that the restitution of Ca 2+ release, as evidenced by the rate of recovery of Ca 2+ transient amplitude, was significantly accelerated in CASQ2 R33Q myocytes, consistent with impaired Ca 2+ signaling refractoriness in these cells (Fig. 2B) . Furthermore, to examine whether these differences in recovery of Ca 2+ release are caused by potential alterations in Ca 2+ currents (I Ca ), we performed measurements of I Ca restitution in patch-clamped myocytes following the same S1-S2 protocol as mentioned previously. The recovery of the peak I Ca was similar in both myocyte groups, suggesting that I Ca is unlikely to underlie the differences in release restitution (Fig. S2) .
To , RyR2 open probability (Po) was significantly higher, whereas the mean closed time (MCT) was significantly shorter in CASQ2 R33Q RyR2s compared with WT channels (Fig. 2 C-F R33Q mice were electrically paced at 1 Hz, and mechanical force was measured before and after exposure to ISO (Fig. 3A) . Under baseline conditions (upper traces), WT and CASQ2 R33Q muscles exhibited regular twitches of similar amplitude and time course (Fig. 3 A, E, and F). Exposure to ISO (30-300 nM; lower traces in Fig. 3A ) effectively tripled the frequency of contractions because of the occurrence of unprovoked diastolic events in CASQ2 R33Q but not in WT muscles. As expected, ISO significantly increased average twitch force amplitude in WT muscles. Interestingly, the average twitch force amplitude at the peak ISO effect remained unchanged in CASQ2 R33Q muscles. This is mainly due to the increased DCR frequency depleting the SR Ca 2+ store (Fig. 3E) . Superimposed traces from different CASQ2 R33Q muscles challenged with ISO are shown in Fig. 3B . As in myocyte experiments, the DCs consistently arose R33Q and WT, respectively; (C-F) n = 59 and 30 cells for CASQ2 R33Q and WT from five and three animals, respectively. *P < 0.05; **P < 0.01.
around three different diastolic time points as illustrated in Fig. 3C . These results suggest that DCs result from highly synchronized cellular events consistent with the temporal alignment of DCR observed in isolated myocytes.
To further assess the cellular synchronicity underlying the observed DCs, we examined the amplitude and decay rate of developed force during stimulated and spontaneous Ca 2+ release ( Fig.  3 E and F). Stimulated contraction (SC) of myocardium is maximally synchronized by electrical stimulus. Thus, we compared the amplitude and decay rate of DCs with SCs to determine the intrinsic synchronicity of the DCs. As demonstrated in Fig. 3D , a significant pool of DCs was similar in size or was even higher than SCs. Taken together, this suggests that most DCs recruited the vast majority of muscle cells and were likely associated with an ectopic AP.
DCR Is Synchronized in Intact CASQ2
R33Q Cardiac Muscle. To directly examine synchronization of DCR between different myocytes in myocardium of CASQ2 R33Q mice, we performed confocal Ca 2+ imaging in cardiac muscle preparations. Muscles loaded with the cytosolic Ca 2+ indicator Rhod-2 were paced at 1 Hz in the presence of ISO (Fig. 4) . Consistent with the results in isolated myocytes, DCR in the form of Ca 2+ waves occurred regularly between pacing-induced Ca 2+ transients in the vast majority of CASQ2 R33Q cells within the field of view ( Fig. 4 B and C) but not in WT muscles (Fig. 4A) . Once again, when we examined the timing of cellular DCRs within cardiac muscles, we observed three distinct time peaks similar to those observed in isolated myocytes (Fig. 4D ). As in isolated myocytes, the distribution of DCRs and DCs in cardiac muscles was rate-dependent ( Fig. S3) . Furthermore, similar to the results of force measurements, the amplitudes of DCRs from a significant portion of myocytes were similar to those of Ca 2+ transients generated by electrical stimulation (Fig. 4E) .
Experiments conducted in isolated myocytes suggest that the temporal alignment of DCR arises from the shortened RyR2 refractory period following temporally uniform stimulated Ca 2+ release and the resultant synchronized reuptake. To test the role of the stimulated Ca 2+ release/reuptake in DCR synchronization, we examined the effects of a single electrical stimulation on the timing of DCR (Fig. 5A , Left). At rest, the muscles exhibited occasional Ca 2+ waves that randomly occurred in different myocytes. Following an electrically induced Ca 2+ transient, several sequential oscillations of Ca 2+ release occurred in multiple adjacent cells, which gradually decreased in amplitude and in the degree of cohesiveness (Fig. 5B) . Application of additional electrical stimuli once again resynchronized the diastolic release (Fig. 5A, Right) . To quantify the degree of synchronicity of DCR, we measured the time interval (i.e., latency) to the first DCR following stimulated Ca 2+ release and the time intervals between consecutive DCRs (Fig. 5C ). The first DCR evidenced the shortest mean latency and smallest corresponding standard deviation (SD), suggesting the highest level of synchronicity. The subsequent DCRs evidenced longer latencies that were coupled to a greater variance in their occurrence. These results suggest that temporally uniform stimulated Ca 2+ release/reuptake dynamics plays a key role in synchronization of DCR in CASQ2 R33Q muscle. Of note, Ca 2+ waves are capable of crossing cell boundaries apparently via gap junctions (25) . However, the rate of propagation of isolated Ca 2+ waves (∼50 μm/s) in our study in the absence of pacing seems too slow to account for the high synchronicity of release in the wake of a temporally aligned pacing-induced Ca 2+ transient. For spontaneous Ca 2+ release to become proarrhythmic, it must cause an ectopic AP that triggers an arrhythmia. As mentioned previously, the high amplitude of DCs and that of DCR events in intact tissue suggest an accompanying muscle-wide triggered electrical depolarization (i.e., extrasystolic AP). R33Q mice compared with WT mice in a one-tail unpaired Student t test. *P < 0.05; **P < 0.01. 1 Hz before and after infusion of ISO. Dual-labeled muscles evidenced an AP and a corresponding Ca 2+ transient with each electrical stimulation (Fig. S4) . Neither DCRs nor extrasystolic APs were detected in WT muscles, even in the presence of ISO (Fig.  S4) . On the other hand, we observed characteristic DCRs that were occasionally associated with extrasystolic APs in single myocytes (Fig. S5 ) as well as globally ( Fig. 6 A and B) in ISO-treated CASQ2 R33Q muscles. Overall, addition of ISO to CASQ2 R33Q muscles resulted in a significant increase in the frequency of cellular DCRs and a corresponding rise in the rate of extrasystolic APs (Fig.  6C) . The generation of cell-wide triggered activity is further substantiated by the similarity in the amplitudes of extrasystolic and electrically stimulated globally averaged AP signals (Fig. 6D) . Taken together, these data suggest that aberrant SR Ca 2+ release can indeed elicit a triggered arrhythmia in a cardiac muscle.
Last, we explored whether stabilization of the release machinery can potentially reverse the proarrhythmic spontaneous Ca 2+ release events. Recent studies have shown that the muscle relaxant dantrolene may normalize abnormal Ca 2+ handling associated with heart failure and CPVT by stabilizing the interdomain interactions within the RyR2 and by increasing the threshold for spontaneous Ca 2+ release in cardiac myocytes (26, 27) . The confocal line-scan images in a CASQ2 R33Q cardiac muscle in Fig. 7A reveal that addition of dantrolene (+ Da) reduced DCR relative to ISO alone. Notably, the tissue-wide extrasystolic Ca 2+ transients characteristic of CASQ2 R33Q (Fig. 7A) were virtually absent following dantrolene exposure. Desynchronization of DCR by dantrolene is further illustrated by increased width of distribution (Fig. 7B) as well as prolonged time to the median (Fig. 7C ) of the first DCR latency in dantrolene-treated muscles. Additionally, dantrolene significantly reduced the frequency of DCR (from 4 to 2.45 per cycle) and the amplitude of the first DCR (Fig. 7D) . Thus, stabilization of RyR2 by dantrolene indeed alleviated aberrant Ca 2+ cycling in CASQ2 R33Q muscle.
Discussion
In this study, we investigated the defective SR Ca 2+ handling mechanisms that underlie triggered arrhythmias associated with CPVT on the molecular, cellular, and tissue levels. Our major finding is that DCR in the form of Ca 2+ waves, commonly thought to result from spontaneous events in individual cells, occurs in a temporally and spatially uniform manner simultaneously in multiple cells across the myocardium of CPVT-susceptible mice. Such highly synchronized Ca 2+ release events give rise to triggered electrical activity and synchronous DCs in intact cardiac muscle. Importantly, we determined that this coordinated, aberrant SR Ca 2+ cycling is due to a combination of impaired refractory behavior of RyR2 channels and synchronous stimulated Ca 2+ release/reuptake dynamics. Our study reveals how DCRs can be synchronized in the myocardium and lead to triggered activity in the setting of a cardiac rhythm disorder.
Synchronicity of DCR and DC in Cardiac Muscle. In this study, we focus on arrhythmogenesis associated with CPVT resulting from a defect in SR Ca 2+ handling caused by a point-mutation (R33Q) in the SR Ca 2+ -binding protein, CASQ2 (22, 24, 28) . Previous studies showed that this and other CASQ2 mutations compromise RyR2 regulation by luminal Ca 2+ , thereby causing DCR and DADs in cardiomyocytes (29) (30) (31) . However, the precise mechanisms as well as the mode(s) of action through which such impaired myocyte Ca 2+ handling on the cellular level leads to CPVT and other forms of Ca 2+ -dependent arrhythmias in intact tissue remain to be defined. Here, we show that DCR in CASQ2 R33Q myocytes occurs in a highly temporally uniform manner with a robust probability, which peaks around 200 ms after stimulated Ca 2+ release ( Fig. 1 E  and F) . This temporal alignment of DCR could provide a basis for synchronization of proarrhythmic Ca 2+ signaling in the myocardium, as noted previously by Stern et al. (32) . We directly confirmed this notion by using measurements of contractile force as well as imaging of the intracellular Ca 2+ and MP in electrically paced ventricular muscles. These studies revealed that indeed both DCRs and DCs occurred in a highly regular manner in CASQ2
R33Q
, but appeared to be random in WT muscles (Fig. 3 B and C) . Importantly, the stabilization of the Ca 2+ release machinery with dantrolene improved regulation of Ca 2+ cycling (27) and ameliorated the CPVT phenotype in our model. Of note, most DCs had amplitude and duration characteristics similar to those of contractions elicited by electrical stimulation. This suggests that, similar to SCs, most DCs involved rapid depolarization of many cells within the tissue and were likely associated with an ectopic AP (Fig. 3D ). This assertion was directly confirmed by monitoring intracellular Ca 2+ and MP in the muscle preparation with confocal microscopy. These experiments revealed that synchronization of DCR in adjacent myocytes was actually able to elicit triggered activity (Fig. 6) . Taken together, these data demonstrate the capacity of DCR to synchronize in ventricular muscle and thereby elicit ectopic activity.
Mechanism of Synchronization of DCR. Based on our findings and results of previous studies (33) (34) (35) (36) , the mechanism of DCR synchronization in CASQ2 R33Q myocardium depends on the efficiency of store-dependent RyR2 deactivation. In normal myocytes, reduction of luminal Ca 2+ following release prompts RyR2s to deactivate via CASQ2, thereby rendering SR release refractory to spontaneous reactivation (7) . In addition, depletion of SR Ca 2+ content can facilitate release refractoriness by reducing Ca 2+ efflux via RyR2s, thus interrupting local CICR signaling (6) . In the CASQ2 R33Q muscle, on the other hand, store-dependent RyR2 deactivation is compromised due to impaired RyR2 regulation by CASQ2, thus leaving SR release vulnerable to spontaneous reactivation (15, 37) . In this study, we show that periodic DCR in CASQ2 R33Q myocytes is associated with impaired Ca 2+ signaling refractoriness, indicated by both shortened restitution of SR Ca 2+ release and increased single RyR2 activity at diastolic luminal Ca 2+ (Fig. 2) . As suggested by Maltsev et al. (23) , impaired Ca 2+ signaling refractoriness increases the propensity of release sites to fire more synchronously by facilitating CICR and local recruitment of neighboring sites. This results in a transition of spontaneous local release events to global waves in cells prone to Ca 2+ oscillations. Moreover, the prolongation of Ca 2+ release refractoriness by dantrolene significantly reduces the probability of the aforementioned release sites to fire synchronously, reducing the proarrhythmic wave burden. Another critical factor in synchronization of DCR revealed here is the temporal uniformity introduced by electrically stimulated Ca 2+ release and reuptake across the myocardium. Thus, impaired refractoriness along with synchronized SR Ca 2+ reuptake provides a dynamic substrate for self-regenerating CICR.
Relation to Previous Studies. Our results are consistent with and expand on previous findings obtained from a postmyocardial infarction canine model of arrhythmia (31) that showed impaired Ca 2+ store-dependent deactivation and compromised Ca 2+ release refractoriness in isolated myocytes (33) . Our findings are supported by experiments in whole hearts of CASQ2 −/− mice that evidenced shortened Ca 2+ release restitution (37) . Furthermore, it has been previously reported that the time course of SR Ca 2+ load influences the timing of spontaneous Ca 2+ release in rat hearts (38) , consistent with our current findings. In this previous study, however, SR Ca 2+ release was only mildly synchronous because of the apparently largely preserved refractory behavior of SR Ca 2+ release of normal rat hearts. This in part may explain why the arrhythmogenic potential of synchronized spontaneous SR Ca 2+ release was not fully revealed as demonstrated here. Last, in accord with reports obtained from myocytes isolated from CPVT mouse (26) and failing rabbit hearts (27) , we demonstrate that synchronized spontaneous SR Ca 2+ release can be disrupted by ] o , n = 70 DCRs from three muscles, **P < 0.01. Stim, stimulated.
pharmacological stabilization of the RyR2 complex and subsequent prolongation of SR Ca 2+ release refractoriness.
Summary. We show that impaired Ca 2+ release refractoriness combined with uniform SR Ca 2+ release in intact cardiac muscle synchronizes the DCR that underlies triggered arrhythmias in CPVT. These aberrant DCRs can be mitigated by pharmacological stabilization of the release machinery that improves abnormally abbreviated SR Ca 2+ release refractoriness. It remains to be determined whether, and to what extent, such synchronization of Ca 2+ release in ventricular myocardium as opposed to other tissue types (i.e., Purkinje fibers) contributes to clinically relevant arrhythmic episodes in CPVT and other forms of Ca 2+ -dependent arrhythmias in the intact heart. Targeting DCR synchronization through reagents affecting RyR2 refractory behavior such as dantrolene may be an innovative strategy for development of mechanism-based antiarrhythmia therapies. No. 85-23, revised 1996] , and by the Animal Care and Use Committee of the University of Padova. Ventricular myocytes were obtained by enzymatic isolation as previously described (39) . I Ca were recorded using whole-cell patch-clamp technique. Fluo-3 (an intracellular Ca 2+ indicator) fluorescence was recorded in the line scan mode of the confocal microscope. SR microsomes were prepared from homogenized WT and CASQ2 R33Q mouse ventricular muscle, and single channels were recorded as previously described (24) . Trabeculae or papillary muscles were used for force measurement as described previously (40 ) knock-in male mice were used; 16 age-matched male C57BL/6 mice (Jackson Laboratory) were used as WT controls. For experiments reported in Fig. 2 C-F Myocyte Isolation, Confocal Ca 2+ Imaging, and I Ca Recordings. Ventricular myocytes were obtained by enzymatic isolation. Mice were anesthetized with isoflurane; after a deep level of anesthesia was reached, the heart was rapidly removed and perfused via a Langendorff perfusion apparatus as previously described (1 3). Myocytes were paced using extracellular platinum electrodes. Any diastolic Ca 2+ release (DCR) event (i.e., wave, wavelet) that increased cell-wide fluorescence intensity above 10% of the signal generated by the preceding stimulated Ca 2+ transient was included in the analysis. The fluorescence emitted was expressed as F/F 0 , where F is the fluorescence at time t and F 0 represents the background signal. All experiments were performed at room temperature (26°C).
Materials and Methods
Single-Channel Preparations. Sarcoplasmic reticulum (SR) microsomes were prepared from WT and CASQ2 R33Q mouse ventricular muscle as follows: frozen tissue was homogenized in five volumes of 0.3 M sucrose, 0.5 mM DTT, 3 mM NaN3, 10 mM imidazole pH 7.4, in the presence of protease inhibitors (PMSF, benzamidine), with a Polytron homogenizer at 21,500 rpm for 15 s, followed by 40 s at 24,000 rpm. The homogenate was centrifuged for 25 min at 3,000 × g. Supernatant was saved and pellet was rehomogenized and spun again at 3,000 × g. Combined supernatants were centrifuged at 20,000 × g for 25 min. After centrifugation, supernatant was filtered and then centrifuged at 120,000 × g for 120 min. The pellet (SR microsomes) was resuspended in the homogenization buffer. Protein was quantified according to Lowry (2) . Planar lipid bilayers were composed of a mixture (5:4:1 mixture, 50 mg/mL in decane) of bovine brain phosphatidylethanolamine, phosphatidylserine, and phosphatidylcholine. The solution on one side of the bilayer (cis side) was virtually grounded and contained 250 mM Hepes, 114 mM Tris (pH 7.4). Heavy SR microsomes (5-15 μg), 500 mM CsCl, and 2 mM CaCl 2 were added to the cis chamber. The solution on the other side of the bilayer (trans) contained 250 mM Hepes, 114 mM Tris (pH 7.4), 1 mM free Ca 2+ (pH 7.4). Microsome fusion into the bilayer always resulted in the cytosolic side of the RyR2 channel facing the cis compartment. The trans solution contained the luminal side of the channel. "Native" channels from these preparations are normally associated with RyR2 accessory proteins including CASQ2, triadin, and junctin (3) (4) (5) . Immediately upon observing single-channel activity, the cytosolic and luminal solutions were changed to the following cell-like recording solutions. The cytosolic cell-like recording solution contained 250 mM Hepes (pH 7.4), 114 mM Tris, 1 μM free Ca 2+ (0.5 mM EGTA), 1 mM free Mg . Note that the luminal side of the channel was never exposed to more than 1 mM Ca 2+ . All recordings were done at room temperature, with current sampled at 50 ms/pt and filtered at 1 kHz. No correction for missing events was made. Recipes for complex solutions were generated using WinMAXC program (Stanford University).
Cardiac Muscle Preparation and Contraction Measurements. Mice were administered heparin (40 μL, heparin sodium 10,000 U/mL, APP Pharmaceuticals, LLC) via i.p. injection 10 min before receiving anesthesia (pentobarbital sodium, 70 mg/kg, i.p., Lundbeck Inc.). The hearts were removed and placed in a modified Krebs-Henseleit (KH) buffer, containing (in mM) 120 NaCl, 5 KCl, 2MgSO 4 , 1.2 NaH 2 PO 4 , 20 NaHCO 3 , 0.25 CaCl 2 , and 10 glucose (pH 7.4), equilibrated with 95% O 2 -5% CO 2 . A total of 20 mM 2,3-butanedione monoxime (BDM) was also added to the dissection buffer to minimize cutting injury (6) . Thin, uniform, nonbranched trabeculae or small papillary muscles were carefully dissected from the right ventricle and mounted between a hook connected to a micromanipulator and a platinum-iridium force transducer as described previously (7, 8) . Average dimensions of the muscles were 1.6 mm long, 0.15 mm wide, and 0.10 mm thick. The dimensions were virtually the same in both strains, and these small dimensions have previously been shown to prevent a hypoxic core in murine muscles under similar conditions (9) . The same KH buffer was used to perfuse the muscles, with the omission of BDM, and the Ca 2+ concentration was raised to 1.5 mM. Muscles were stretched to an optimal length (i.e., where an increase in length led to approximately equal increases in both the resting and the active developed tension) and allowed to stabilize for at least 15 min at a baseline pacing frequency of 1 Hz before starting the experimental protocol. It has been shown that this muscle length corresponds with a sarcomere length of around 2.2-2.3 μm (10). The cross-sectional area of each muscle was used to normalize the developed force and allow for comparison between muscles of different diameters. Force data are presented in mN/mm 2 . All experiments were performed at room temperature.
Cardiac Muscles Confocal Ca 2+ and Membrane Potential Imaging. The recording chamber was placed on the stage of an Olympus FluoView 1000 laser scanning confocal microscope, equipped with a 5 mW He-Ne laser and an UPLSAPO 60× water objective (N.A. 1.20, working distance 0.28 mm). Muscles were loaded with the cytosolic Ca 2+ indicator Rhod-2 AM (40 μM), dissolved in 2% (vol/vol) Pluronic (20% wt/vol) in 1 mL KH buffer, for 45 min. Tetrakis-(2-Pyridylmethyl)ethylenediamine (TPEN) (4.3 mg/L) and Cremophor (5 mg/L) were also added to the dye solution. The electrical stimulation was turned on at 1 Hz frequency during the last 5 min of incubation. For some experiments, the muscles were also stained with either the membrane potential (MP) indicator RH237 (30 μL of a 1.25 mg/mL DMSO solution in 1 mL of KH buffer for 10 min) or di-4-ANBDQBS (Richard D. Berlin Center for Cell Analysis and Modeling, University of Connecticut Health Center; 25 μL of a 2.5 mg/mL DMSO solution for 10 min) (11) after Rhod-2 loading. The muscles were then slacked and extensively washed with fresh KH buffer containing 5-8 mM BDM and 10-20 μM blebbistatin to stop cell contraction and allow for Ca 2+ imaging. A microtool connected to a micromanipulator was also used to push the muscle against the coverslip to optimize the resolution. Line-scan images were acquired at the rate of 8 μs/pixel. The fluorescence emitted was expressed as F/F 0 . All experiments were performed at room temperature.
Reagents. Unless otherwise stated, all chemicals were purchased from Sigma or Calbiochem. Fluorescent dyes were purchased from Molecular Probes.
Data Analysis. Single-channel analysis was done using pCLAMP9 software (Molecular Devices). Force data were collected and analyzed using custom-designed software (LabView; National Instruments). Line scanning images of Ca 2+ and MP were normalized for baseline fluorescence (12) . Ca 2+ and MP imaging data were processed using ImageJ and Origin software. Data are presented as means ± SEM. Statistical analyses were performed using Student's paired or unpaired t tests. Two-tailed P < 0.05 was accepted as statistically significant. myocytes, respectively. Data were fit to monoexponential function with constant of 284 ± 27 ms in WT and 264 ± 24 ms in CASQ2 R33Q . Peak density of I Ca measured at 0 mV was not significantly different (P = 0.4) between WT (−9.64 ± 0.6 pA/pF, n = 8) and CASQ2 R33Q (−8.76 ± 0.8 pA/pF, n = 10) groups. pA/pF, picoampere/picofarad. 
